[Bone metastasis from gastrinoma without hepatic involvement. Utility of the scintigraphy with 111 In-pentetreotide].
The case of a 54 year old patient suffering from gastrinoma (within a type I multiple endocrine neoplasm) is presented. In 1990, she underwent a surgical resection. Eight years later, she suffered from a pain in the left thigh. The 99mTc-MDP bone scintigraphy showed bone metastasis. The CT scan did not show any hepatic involvement and the scintigraphy with 111In-Pentetreotide verified bone metastasis of a neuroendocrine tumor as a single expression of the recidive. In this case, the utility of the scintigraphy with octreotide to facilitate the localization and extent of the neuroendocrine tumors is demonstrated.
Cortés
M
M
Servicio de Medicina Nuclear del Hospital de Bellvitge. L'Hospital de Llobregat. Barcelona.
Mora
J
J
Benítez
A
A
González
M J
MJ
Castell
M
M
Martín-Comín
J
J
D000315:Adrenalectomy; D005260:Female; D005266:Femoral Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000556:secondary*; D015408:Gastrinoma / Q000150:complications / Q000000981:diagnostic imaging / Q000532:radiotherapy / Q000556:secondary*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology; D008099:Liver / Q000000981:diagnostic imaging; D008875:Middle Aged; D018761:Multiple Endocrine Neoplasia Type 1 / Q000000981:diagnostic imaging*; D010166:Palliative Care; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000150:complications / Q000473:pathology* / Q000601:surgery; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013004:Somatostatin / Q000031:analogs & derivatives*; D013156:Splenectomy; D015043:Zollinger-Ellison Syndrome / Q000209:etiology
D019275:Radiopharmaceuticals; D013004:Somatostatin; C081788:pentetreotide